(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of DDX39A mRNA] CTD PMID:31150632 (-)-epigallocatechin 3-gallate decreases expression ISO DDX39A (Homo sapiens) 6480464 epigallocatechin gallate results in decreased expression of DDX39A protein CTD PMID:31195006 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression EXP 6480464 o and p'-DDT results in increased expression of DDX39A mRNA CTD PMID:24096037 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane increases expression ISO Ddx39a (Mus musculus) 6480464 o and p'-DDT results in increased expression of DDX39A mRNA CTD PMID:24096037 1,2-dichloroethane increases expression ISO Ddx39a (Mus musculus) 6480464 ethylene dichloride results in increased expression of DDX39A mRNA CTD PMID:28189721 and PMID:28960355 1,2-dimethylhydrazine multiple interactions ISO Ddx39a (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DDX39A mRNA CTD PMID:22206623 17alpha-ethynylestradiol multiple interactions ISO Ddx39a (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DDX39A mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of DDX39A mRNA CTD PMID:24096037 17alpha-ethynylestradiol affects expression ISO Ddx39a (Mus musculus) 6480464 Ethinyl Estradiol affects the expression of DDX39A mRNA CTD PMID:17555576 17alpha-ethynylestradiol increases expression ISO Ddx39a (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of DDX39A mRNA CTD PMID:17942748 and PMID:24096037 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of DDX39A mRNA CTD PMID:32145629 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 AHR protein alternative form affects the reaction [Tetrachlorodibenzodioxin results in decreased expression of DDX39A mRNA] CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Ddx39a (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DDX39A mRNA CTD PMID:17942748 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of DDX39A mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Ddx39a (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of DDX39A mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Ddx39a (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of DDX39A mRNA CTD PMID:19465110 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of DDX39A mRNA CTD PMID:21215274 2,4-dinitrotoluene affects expression EXP 6480464 2 and 4-dinitrotoluene affects the expression of DDX39A mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2 and 6-dinitrotoluene affects the expression of DDX39A mRNA CTD PMID:21346803 2-butoxyethanol increases expression ISO Ddx39a (Mus musculus) 6480464 n-butoxyethanol results in increased expression of DDX39A mRNA CTD PMID:19812364 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:23196670 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO DDX39A (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of DDX39A mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of DDX39A mRNA CTD PMID:36041667 4,4'-sulfonyldiphenol affects methylation ISO Ddx39a (Mus musculus) 6480464 bisphenol S affects the methylation of DDX39 gene CTD PMID:31683443 4-hydroxyphenyl retinamide increases expression ISO Ddx39a (Mus musculus) 6480464 Fenretinide results in increased expression of DDX39A mRNA CTD PMID:28973697 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of DDX39A mRNA CTD PMID:30047161 acetamide increases expression EXP 6480464 acetamide results in increased expression of DDX39A mRNA CTD PMID:31881176 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of DDX39A mRNA CTD PMID:28959563 aflatoxin B1 increases expression ISO DDX39A (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of DDX39A mRNA CTD PMID:27153756 aflatoxin B1 increases methylation ISO DDX39A (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of DDX39A intron CTD PMID:30157460 aflatoxin B1 increases expression ISO Ddx39a (Mus musculus) 6480464 Aflatoxin B1 results in increased expression of DDX39A mRNA CTD PMID:19770486 all-trans-retinoic acid decreases expression ISO DDX39A (Homo sapiens) 6480464 Tretinoin results in decreased expression of DDX39A mRNA CTD PMID:16249480 amiodarone increases expression ISO DDX39A (Homo sapiens) 6480464 Amiodarone results in increased expression of DDX39A mRNA CTD PMID:19774075 amitrole increases expression EXP 6480464 Amitrole results in increased expression of DDX39A mRNA CTD PMID:30047161 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of DDX39A mRNA CTD PMID:16483693 atrazine decreases expression ISO DDX39A (Homo sapiens) 6480464 Atrazine results in decreased expression of DDX39A mRNA CTD PMID:22378314 benzo[a]pyrene increases expression ISO Ddx39a (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of DDX39A mRNA CTD PMID:19770486 benzo[a]pyrene affects methylation ISO DDX39A (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of DDX39 promoter and Benzo(a)pyrene affects the methylation of DDX39A intron CTD PMID:27901495 and PMID:30157460 benzo[a]pyrene diol epoxide I decreases expression ISO DDX39A (Homo sapiens) 6480464 7 more ... CTD PMID:20382639 bis(2-ethylhexyl) phthalate increases expression ISO DDX39A (Homo sapiens) 6480464 Diethylhexyl Phthalate results in increased expression of DDX39A protein CTD PMID:31163220 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of DDX39A mRNA CTD PMID:25181051 more ... bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of DDX39A mRNA CTD PMID:36041667 bisphenol A decreases expression ISO DDX39A (Homo sapiens) 6480464 bisphenol A results in decreased expression of DDX39A protein CTD PMID:37567409 bisphenol A increases expression ISO DDX39A (Homo sapiens) 6480464 bisphenol A results in increased expression of DDX39A protein CTD PMID:33376534 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of DDX39A mRNA CTD PMID:32145629 bisphenol A decreases expression ISO Ddx39a (Mus musculus) 6480464 bisphenol A results in decreased expression of DDX39A mRNA CTD PMID:26063408 bisphenol A multiple interactions ISO DDX39A (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of DDX39A mRNA CTD PMID:28628672 bisphenol F multiple interactions EXP 6480464 [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of DDX39A mRNA CTD PMID:36041667 butyric acid decreases expression EXP 6480464 Butyric Acid results in decreased expression of DDX39A mRNA CTD PMID:12800193 caffeine decreases expression ISO DDX39A (Homo sapiens) 6480464 Caffeine results in decreased expression of DDX39A protein CTD PMID:31195006 caffeine affects phosphorylation ISO DDX39A (Homo sapiens) 6480464 Caffeine affects the phosphorylation of DDX39A protein CTD PMID:35688186 calcitriol multiple interactions ISO DDX39A (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of DDX39A mRNA CTD PMID:21592394 calcitriol decreases expression ISO DDX39A (Homo sapiens) 6480464 Calcitriol results in decreased expression of DDX39A mRNA CTD PMID:21592394 cannabidiol increases expression ISO Ddx39a (Mus musculus) 6480464 Cannabidiol results in increased expression of DDX39 mRNA CTD PMID:31052254 carbamazepine affects expression ISO DDX39A (Homo sapiens) 6480464 Carbamazepine affects the expression of DDX39A mRNA CTD PMID:25979313 carbon nanotube increases expression ISO Ddx39a (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 cefaloridine increases expression EXP 6480464 Cephaloridine results in increased expression of DDX39A mRNA CTD PMID:18500788 chromium(6+) affects expression ISO Ddx39a (Mus musculus) 6480464 chromium hexavalent ion affects the expression of DDX39A mRNA CTD PMID:28472532 cisplatin decreases expression ISO DDX39A (Homo sapiens) 6480464 Cisplatin results in decreased expression of DDX39A protein CTD PMID:20540955 clofibric acid affects expression EXP 6480464 Clofibric Acid affects the expression of DDX39A mRNA CTD PMID:17602206 clotrimazole increases expression EXP 6480464 Clotrimazole results in increased expression of DDX39A mRNA CTD PMID:30047161 copper atom multiple interactions ISO DDX39A (Homo sapiens) 6480464 [Disulfiram binds to Copper] which results in decreased expression of DDX39A mRNA CTD PMID:24690739 copper(0) multiple interactions ISO DDX39A (Homo sapiens) 6480464 [Disulfiram binds to Copper] which results in decreased expression of DDX39A mRNA CTD PMID:24690739 copper(II) sulfate increases expression ISO DDX39A (Homo sapiens) 6480464 Copper Sulfate results in increased expression of DDX39A mRNA CTD PMID:19549813 coumestrol increases expression ISO DDX39A (Homo sapiens) 6480464 Coumestrol results in increased expression of DDX39A mRNA CTD PMID:19167446 cyclosporin A increases expression ISO DDX39A (Homo sapiens) 6480464 Cyclosporine results in increased expression of DDX39A mRNA CTD PMID:20106945 and PMID:25562108 deoxynivalenol increases expression ISO DDX39A (Homo sapiens) 6480464 deoxynivalenol results in increased expression of DDX39A mRNA CTD PMID:31863870 dexamethasone multiple interactions ISO DDX39A (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of DDX39A mRNA CTD PMID:28628672 diazinon increases methylation ISO DDX39A (Homo sapiens) 6480464 Diazinon results in increased methylation of DDX39A gene CTD PMID:22964155 dibutyl phthalate decreases expression ISO Ddx39a (Mus musculus) 6480464 Dibutyl Phthalate results in decreased expression of DDX39A mRNA CTD PMID:17361019 and PMID:21266533 dicrotophos increases expression ISO DDX39A (Homo sapiens) 6480464 dicrotophos results in increased expression of DDX39A mRNA CTD PMID:28302478 dioxygen multiple interactions ISO Ddx39a (Mus musculus) 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of DDX39A mRNA CTD PMID:30529165 disulfiram multiple interactions ISO DDX39A (Homo sapiens) 6480464 [Disulfiram binds to Copper] which results in decreased expression of DDX39A mRNA CTD PMID:24690739 doxorubicin increases expression ISO DDX39A (Homo sapiens) 6480464 Doxorubicin results in increased expression of DDX39A mRNA CTD PMID:29803840 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of DDX39A mRNA CTD PMID:29391264 flutamide increases expression EXP 6480464 Flutamide results in increased expression of DDX39A mRNA CTD PMID:24136188 folic acid multiple interactions ISO Ddx39a (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of DDX39A mRNA CTD PMID:22206623 FR900359 affects phosphorylation ISO DDX39A (Homo sapiens) 6480464 FR900359 affects the phosphorylation of DDX39A protein CTD PMID:37730182 fulvestrant increases methylation ISO DDX39A (Homo sapiens) 6480464 Fulvestrant results in increased methylation of DDX39A gene CTD PMID:31601247 furan increases methylation EXP 6480464 furan results in increased methylation of DDX39A gene CTD PMID:22079235 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of DDX39A mRNA CTD PMID:22061828 and PMID:33387578 glafenine increases expression EXP 6480464 Glafenine results in increased expression of DDX39A mRNA CTD PMID:24136188 glyphosate increases expression EXP 6480464 Glyphosate results in increased expression of DDX39A mRNA CTD PMID:26302742 indometacin multiple interactions ISO DDX39A (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of DDX39A mRNA CTD PMID:28628672 inulin multiple interactions ISO Ddx39a (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of DDX39 mRNA CTD PMID:36331819 ivermectin decreases expression ISO DDX39A (Homo sapiens) 6480464 Ivermectin results in decreased expression of DDX39A protein CTD PMID:32959892 lead diacetate affects expression ISO Ddx39a (Mus musculus) 6480464 lead acetate affects the expression of DDX39A mRNA CTD PMID:21829687 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of DDX39A mRNA CTD PMID:18619722 and PMID:28935588 methimazole increases expression EXP 6480464 Methimazole results in increased expression of DDX39A mRNA CTD PMID:30047161 nefazodone increases expression EXP 6480464 nefazodone results in increased expression of DDX39A mRNA CTD PMID:24136188 nickel atom increases expression ISO DDX39A (Homo sapiens) 6480464 Nickel results in increased expression of DDX39A mRNA CTD PMID:24768652 and PMID:25583101 nimesulide increases expression EXP 6480464 nimesulide results in increased expression of DDX39A mRNA CTD PMID:24136188 oxaliplatin multiple interactions EXP 6480464 [Oxaliplatin co-treated with Topotecan] results in decreased expression of DDX39A mRNA CTD PMID:25729387 ozone multiple interactions ISO Ddx39a (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of DDX39A mRNA CTD PMID:34911549 paracetamol affects expression ISO Ddx39a (Mus musculus) 6480464 Acetaminophen affects the expression of DDX39A mRNA CTD PMID:17562736 paracetamol increases expression ISO Ddx39a (Mus musculus) 6480464 Acetaminophen results in increased expression of DDX39A mRNA CTD PMID:19420014 paraquat increases expression EXP 6480464 Paraquat results in increased expression of DDX39A mRNA CTD PMID:32680482 pentachlorophenol increases expression ISO Ddx39a (Mus musculus) 6480464 Pentachlorophenol results in increased expression of DDX39A mRNA CTD PMID:23892564 perfluorooctane-1-sulfonic acid multiple interactions ISO Ddx39a (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of DDX39 mRNA CTD PMID:36331819 perfluorooctanoic acid increases expression EXP 6480464 perfluorooctanoic acid results in increased expression of DDX39A mRNA CTD PMID:19162173 phenobarbital affects expression ISO Ddx39a (Mus musculus) 6480464 Phenobarbital affects the expression of DDX39A mRNA CTD PMID:23091169 phosgene affects expression ISO Ddx39a (Mus musculus) 6480464 Phosgene affects the expression of DDX39A mRNA CTD PMID:16300373 piperonyl butoxide increases expression EXP 6480464 Piperonyl Butoxide results in increased expression of DDX39A mRNA CTD PMID:22484513 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of DDX39A mRNA CTD PMID:19162173 piroxicam decreases expression ISO DDX39A (Homo sapiens) 6480464 Piroxicam results in decreased expression of DDX39A mRNA CTD PMID:21858171 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of DDX39A mRNA CTD PMID:30047161 progesterone decreases expression EXP 6480464 Progesterone results in decreased expression of DDX39A mRNA CTD PMID:20726854 propiconazole increases expression EXP 6480464 propiconazole results in increased expression of DDX39A mRNA CTD PMID:30047161 quercetin increases expression ISO DDX39A (Homo sapiens) 6480464 Quercetin results in increased expression of DDX39A mRNA CTD PMID:21632981 SB 431542 multiple interactions ISO DDX39A (Homo sapiens) 6480464 [LDN 193189 co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in decreased expression of DDX39A protein CTD PMID:37664457 silver atom increases expression ISO Ddx39a (Mus musculus) 6480464 Silver results in increased expression of DDX39A mRNA CTD PMID:27131904 silver(0) increases expression ISO Ddx39a (Mus musculus) 6480464 Silver results in increased expression of DDX39A mRNA CTD PMID:27131904 sodium arsenite increases expression ISO DDX39A (Homo sapiens) 6480464 sodium arsenite results in increased expression of DDX39A mRNA CTD PMID:28595984 and PMID:34032870 sodium dichromate increases expression EXP 6480464 sodium bichromate results in increased expression of DDX39A mRNA CTD PMID:25993096 sodium fluoride increases expression ISO Ddx39a (Mus musculus) 6480464 Sodium Fluoride results in increased expression of DDX39A protein CTD PMID:27548804 Soman increases expression EXP 6480464 Soman results in increased expression of DDX39A mRNA CTD PMID:19281266 sulfadimethoxine increases expression EXP 6480464 Sulfadimethoxine results in increased expression of DDX39A mRNA CTD PMID:30047161 tamoxifen affects expression ISO Ddx39a (Mus musculus) 6480464 Tamoxifen affects the expression of DDX39A mRNA CTD PMID:17555576 testosterone multiple interactions ISO DDX39A (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of DDX39A mRNA CTD PMID:21592394 testosterone decreases expression ISO DDX39A (Homo sapiens) 6480464 Testosterone results in decreased expression of DDX39A mRNA CTD PMID:21592394 tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of DDX39A mRNA CTD PMID:31150632 tetrachloromethane increases expression ISO Ddx39a (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of DDX39A mRNA CTD PMID:27339419 and PMID:31919559 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of DDX39A mRNA] CTD PMID:31150632 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of DDX39A mRNA CTD PMID:18619722 more ... titanium dioxide increases expression ISO Ddx39a (Mus musculus) 6480464 titanium dioxide results in increased expression of DDX39A mRNA CTD PMID:27760801 topotecan multiple interactions EXP 6480464 [Oxaliplatin co-treated with Topotecan] results in decreased expression of DDX39A mRNA CTD PMID:25729387 trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of DDX39A mRNA CTD PMID:33387578 trimellitic anhydride increases expression ISO Ddx39a (Mus musculus) 6480464 trimellitic anhydride results in increased expression of DDX39A mRNA CTD PMID:19042947 triptonide decreases expression ISO Ddx39a (Mus musculus) 6480464 triptonide results in decreased expression of DDX39A mRNA CTD PMID:33045310 tungsten increases expression ISO Ddx39a (Mus musculus) 6480464 Tungsten results in increased expression of DDX39A mRNA CTD PMID:30912803 valproic acid increases expression ISO DDX39A (Homo sapiens) 6480464 Valproic Acid results in increased expression of DDX39A mRNA CTD PMID:23179753 valproic acid affects expression ISO DDX39A (Homo sapiens) 6480464 Valproic Acid affects the expression of DDX39A mRNA CTD PMID:25979313 valproic acid affects expression ISO Ddx39a (Mus musculus) 6480464 Valproic Acid affects the expression of DDX39A mRNA CTD PMID:17292431